Page last updated: 2024-08-25

2-(hydroxymethyl)anthraquinone and Breast Neoplasms

2-(hydroxymethyl)anthraquinone has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bokser, L; Halmos, G; Janáky, T; Juhász, A; Milovanovic, S; Pinski, J; Redding, TW; Rékási, Z; Serfözö, P; Srkalovic, G1

Other Studies

1 other study(ies) available for 2-(hydroxymethyl)anthraquinone and Breast Neoplasms

ArticleYear
Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Nov-01, Volume: 89, Issue:21

    Topics: Amino Acid Sequence; Animals; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Cell Membrane; Cell Survival; Cisplatin; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Melphalan; Methotrexate; Molecular Sequence Data; Oligopeptides; Orchiectomy; Pituitary Gland; Prostatic Neoplasms; Rats; Receptors, LHRH; Structure-Activity Relationship; Tumor Cells, Cultured

1992